Skip to main content

Table 2 Baseline clinical characteristics of each cohort

From: Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis

N =251/group   Group A (RA) Group B (DM) Group C (GP) P, All three P, A versus C
Exercise status No data 165 (66%) 145 (58%) 154 (61%) < 0.0001 < 0.0001
  Never 30 (12%) 46 (18%) 29 (12%)   
  Infrequently 1-2×/week 15 (6%) 11 (4%) 9 (4%)   
  Moderately 3-5×/week 31 (12%) 18 (7%) 15 (6%)   
  Regularly > 5×/week 10 (4%) 31 (12%) 43 (17%)   
BMI   28.5 (7.5) 34.9 (8.9) 28.8 (7.9) < 0.0001 0.4
Smoking status Never 167 (67%) 155 (62%) 151 (60%) 0.2 0.7
  Past 48 (19%) 48 (19%) 44 (18%)   
  Current 36 (14%) 48 (19%) 56 (22%)   
SBP   121.8 (13.0) 130.5 (13.0) 125.0 (14.1) < 0.0001 0.02
DBP   73.3 (7.6) 72.9 (8.6) 73.2 (8.0) 0.6 0.8
Number BP measurements   6.5 (5.8) 5.8 (2.9) 4.3 (3.0) < 0.0001 < 0.0001
HDL   58.3 (17.1) 46.8 (12.9) 54.3 (15.9) < 0.0001 0.01
LDL   113.7 (32.4) 99.5 (37.1) 111.4 (29.1) < 0.0001 0.5
Triglycerides   116.9 (64.1) 192.8 (178.9) 130.6 (79.4) < 0.0001 0.1
Fasting glucose Mean (std) 90.3 (9.3) 165.5 (82.3) 93.6 (10.7) < 0.0001 0.003
  N 206 166 175   
  1. BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; DM, diabetes mellitus; GP, general population; HDL, high-density lipoprotein; LDL, low-density lipoprotein; RA, rheumatoid arthritis; SBP, systolic blood pressure.